Cited by 249Adenosine and Purinergic SignalingPain Mechanisms and TreatmentsCalcium signaling and nucleotide metabolism

The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression

Open access
Burnstock, Geoffrey, Knight, Gillian E.·2018·Purinergic Signalling

Abstract

Seven P2X ion channel nucleotide receptor subtypes have been cloned and characterised. P2X7 receptors (P2X7R) are unusual in that there are extra amino acids in the intracellular C terminus. Low concentrations of ATP open cation channels sometimes leading to cell proliferation, whereas high concentrations of ATP open large pores that release inflammatory cytokines and can lead to apoptotic cell death. Since many diseases involve inflammation and immune responses, and the P2X7R regulates inflammation, there has been recent interest in the pathophysiological roles of P2X7R and the potential of P2X7R antagonists to treat a variety of diseases. These include neurodegenerative diseases, psychiatric disorders, epilepsy and a number of diseases of peripheral organs, including the cardiovascular, airways, kidney, liver, bladder, skin and musculoskeletal. The potential of P2X7R drugs to treat tumour progression is discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11302-017-9593-0

Cites

228 of 228 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • P2X7R-mediated effects, mainly through activation of the neuroinflammatory response, have been involved in MDD, neurodegenerative diseases, schizophrenia, epilepsy, neuropathic pain, and brain injury.

    “P2X7R-mediated effects, which mainly occurs through activation of the neuroinflammatory response, have been involved in MDD, neurodegenerative diseases, schizophrenia, epilepsy, neuropathic pain and brain injury [28,66,67,68].”

    From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [66]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Burnstock, G., & Knight, G. E.
Affiliations
  • The University of Melbourne (AU)
  • University College London (GB)
Corresponding author
Burnstock, Geoffrey
Venue
Purinergic Signalling
Published
2017-11-21
Volume
14
Issue
1
Pages
1-18
ISSN
  • 1573-9538 (ISSN-L)
  • 1573-9546
OpenAlex
W2768734810
Cited by
248
References
228
Citations by year
2026: 13 · 2025: 20 · 2024: 22 · 2023: 25 · 2022: 28 · 2021: 48 · 2020: 52 · 2019: 27 · 2018: 13
FWCI
2.65
Type
journal article
Language
en
Open access
Locations
  • Purinergic Signalling (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Funders
University College London (UCL)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
Keywords
P2X7 receptor, ATP, P2X7 receptor antagonists, inflammation, tumor progression, apoptosis, neurodegenerative diseases, mental illness, epilepsy, therapeutic target
MeSH terms
Animals, Humans, Inflammation, Neoplasms, Disease Progression, Receptors, Purinergic P2X7, Purinergic P2X Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review